{
  "chapter_title": "Corporate Structure / Group Chart",
  "section_title": "Corporate Structure / Group Chart",
  "description": "Ownership structure, subsidiaries, ultimate beneficial owners (UBOs), holding companies, and group entities.",
  "questions": [
    {
      "question": "What is the ownership structure of Ion Beam Applications SA, including parent companies and subsidiaries?",
      "queries": [
        {
          "query": "Ion Beam Applications SA ownership structure",
          "results": [
            {
              "text": "=== Page 185 ===\nIBA Annual Report 2021 \n182. CORPORATE NAME \nIon Beam Applications SA, abbreviated IBA SA. Following a resolution of the Extraordinary \nGeneral Meeting of shareholders of the \nCompany held on June 14, 2023 article 1 of the \nbylaws has been amended and now reads as \nfollows: Article 1: The Company takes the form of a public limited \ncompany. The name of the Company is Ion \nBeam Applications and, in short, IBA. \" \nREGISTERED OFFICE \nChemin du Cyclotron, 3; B-1348 Louvain-la-\nNeuve",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "parent companies Ion Beam Applications SA",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "subdivisions Ion Beam Applications SA",
          "results": [
            {
              "text": "The consolidated accounts of Ion Beam Application SA for the fiscal year ended on December 31, 2022, have been audited by another auditor who expressed an unqualified opinion on these \nconsolidated accounts in their report dated April 28, 2023. Responsibilities of the board of directors for the preparation of the consolidated accounts",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "Who are the ultimate beneficial owners (UBOs) behind Ion Beam Applications SA and their respective roles within the company?",
      "queries": [
        {
          "query": "ultimate beneficial owners Ion Beam Applications SA",
          "results": [
            {
              "text": "00% \n100% \nIon Beam Beijing Applications Co. Ltd. Beijing, China \n100% \n100% \nIBA RadioIsotopes France SAS \nLyon, France \n100% \n100% \nIBA Dosimetry Ltd. Schwarzenbruck, Germany \n100% \n100% \nIBA Dosimetry America Inc. Bartlett, USA \n100% \n100% \nIBA Proton Therapy Inc. Edgewood New York, USA \n100% \n100% \nIBA Industrial Inc. Edgewood New York, USA \n100% \n100% \nIBA USA Inc. Edgewood New York, USA \n100% \n100% \nIBA Particle Therapy Ltd.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "Ion Beam Applications SA UBOs",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "key individuals involved in Ion Beam Applications SA",
          "results": [
            {
              "text": "The consolidated accounts of Ion Beam Application SA for the fiscal year ended on December 31, 2022, have been audited by another auditor who expressed an unqualified opinion on these \nconsolidated accounts in their report dated April 28, 2023. Responsibilities of the board of directors for the preparation of the consolidated accounts",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "What is the corporate hierarchy, including holding companies and group entities, of Ion Beam Applications SA?",
      "queries": [
        {
          "query": "corporate hierarchy Ion Beam Applications SA",
          "results": [
            {
              "text": "=== Page 185 ===\nIBA Annual Report 2021 \n182. CORPORATE NAME \nIon Beam Applications SA, abbreviated IBA SA. Following a resolution of the Extraordinary \nGeneral Meeting of shareholders of the \nCompany held on June 14, 2023 article 1 of the \nbylaws has been amended and now reads as \nfollows: Article 1: The Company takes the form of a public limited \ncompany. The name of the Company is Ion \nBeam Applications and, in short, IBA. \" \nREGISTERED OFFICE \nChemin du Cyclotron, 3; B-1348 Louvain-la-\nNeuve",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "holding companies related to Ion Beam Applications SA",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "group entities connected to Ion Beam Applications SA",
          "results": [
            {
              "text": "=== Page 118 ===\nIBA Annual Report 2023 \n115. 1. Summary of significant group accounting \npolicies \n1.1. THE REPORTING ENTITY \nIon Beam Applications SA (the Company or \nthe Parent), founded in 1986, and its \nsubsidiaries (together, the Group or IBA) are \ncommitted to technological progress in the field \nof cancer diagnosis and therapy and deliver \nefficient, dependable \nsolutions \nproviding \nunequalled precision. IBA also offers innovative \nsolutions for everyday hygiene and safety. The \nCompany \nis \na \nlimited \ncompany \nincorporated and domiciled in Belgium.",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "Are there any known connections or affiliations between Ion Beam Applications SA and other organizations, individuals, or government agencies?",
      "queries": [
        {
          "query": "affiliations Ion Beam Applications SA",
          "results": [
            {
              "text": "The consolidated accounts of Ion Beam Application SA for the fiscal year ended on December 31, 2022, have been audited by another auditor who expressed an unqualified opinion on these \nconsolidated accounts in their report dated April 28, 2023. Responsibilities of the board of directors for the preparation of the consolidated accounts",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "known connections Ion Beam Applications SA",
          "results": [
            {
              "text": "The consolidated accounts of Ion Beam Application SA for the fiscal year ended on December 31, 2022, have been audited by another auditor who expressed an unqualified opinion on these \nconsolidated accounts in their report dated April 28, 2023. Responsibilities of the board of directors for the preparation of the consolidated accounts",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "linked entities with Ion Beam Applications SA",
          "results": [
            {
              "text": "00% \n100% \nIon Beam Beijing Applications Co. Ltd. Beijing, China \n100% \n100% \nIBA RadioIsotopes France SAS \nLyon, France \n100% \n100% \nIBA Dosimetry Ltd. Schwarzenbruck, Germany \n100% \n100% \nIBA Dosimetry America Inc. Bartlett, USA \n100% \n100% \nIBA Proton Therapy Inc. Edgewood New York, USA \n100% \n100% \nIBA Industrial Inc. Edgewood New York, USA \n100% \n100% \nIBA USA Inc. Edgewood New York, USA \n100% \n100% \nIBA Particle Therapy Ltd.",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    }
  ]
}